Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.
Olesen TB, Andersen IT, Ording AG, Ehrenstein V, Seesaghur A, Helleberg C, Silkjær T, Hernandez RK, Niepel D, Abildgaard N. Olesen TB, et al. Among authors: silkjaer t. Support Care Cancer. 2021 Aug;29(8):4501-4511. doi: 10.1007/s00520-020-05934-8. Epub 2021 Jan 18. Support Care Cancer. 2021. PMID: 33458807
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Szabo AG, Klausen TW, Abildgaard N, Gregersen H, Silkjær T, Pedersen PT, Pedersen RS, Helleberg C, Hermansen E, Schnack BI, Vangsted AJ. Szabo AG, et al. Among authors: silkjaer t. Blood Cancer J. 2021 Apr 7;11(4):70. doi: 10.1038/s41408-021-00460-0. Blood Cancer J. 2021. PMID: 33828079 Free PMC article. No abstract available.
Potential value of pre-planned imaging of bone disease in multiple myeloma.
Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T; Nordic Myeloma Study Group. Gundesen MT, et al. Among authors: silkjaer t. Blood Cancer J. 2023 Jul 7;13(1):105. doi: 10.1038/s41408-023-00880-0. Blood Cancer J. 2023. PMID: 37419876 Free PMC article. No abstract available.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F; Nordic Myeloma Study Group. Lund T, et al. Among authors: silkjaer t. Blood Cancer J. 2024 Apr 15;14(1):65. doi: 10.1038/s41408-024-01046-2. Blood Cancer J. 2024. PMID: 38622134 Free PMC article. No abstract available.
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
Nielsen LK, Mercieca-Bebber R, Möller S, Redder L, Jarden M, Andersen CL, Frederiksen H, Svirskaite A, Silkjær T, Steffensen MS, Pedersen PT, Hinge M, Frederiksen M, Jensen BA, Helleberg C, Mylin AK, Abildgaard N, King MT. Nielsen LK, et al. Among authors: silkjaer t. Qual Life Res. 2024 Sep;33(9):2387-2400. doi: 10.1007/s11136-024-03707-y. Epub 2024 Jun 16. Qual Life Res. 2024. PMID: 38879861 Free PMC article.
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.
Harsløf M, Chanchiri I, Silkjær T, Frølund UC, Teodorescu EM, Nielsen KB, Nielsen PI, Pedersen PT, Iversen KF, Lund T, Grønbæk K, Thorsteinsdottir S, Vangsted A, Szabo AG. Harsløf M, et al. Among authors: silkjaer t. EJHaem. 2024 Mar 27;5(2):316-324. doi: 10.1002/jha2.881. eCollection 2024 Apr. EJHaem. 2024. PMID: 38633122 Free PMC article.
[Monoclonal gammopathy of undetermined significance].
Hermansen NEU, Silkjær T, Hansen CT, Aagaard TG, Gregersen H. Hermansen NEU, et al. Among authors: silkjaer t. Ugeskr Laeger. 2020 Mar 2;182(10):V08190428. Ugeskr Laeger. 2020. PMID: 32138824 Free article. Review. Danish.
13 results